Neoadjuvant S-1 plus cisplatin-based chemoradiotherapy compared with surgery alone for locally advanced gastric cancer: Randomized, phase II trial

被引：0
|
作者：
Hong, Moonki
Yun, Kum-Hee
Jung, Minkyu
Rha, Sun Young
Kim, Hyoung-Il
Park, Jun Chul
Lee, Sang Kil
Choi, Seo Hee
Jung, Inkyung
Lim, Joon Seok
Hyung, Woo Jin
Koom, Woong Sub
Kim, Hyo Song
机构：
[1] Yonsei Univ, Div Med Oncol, Dept Internal Med, Yonsei Canc Ctr,Coll Med, Seoul, South Korea
[2] Yonsei Univ, SongDang Inst Canc Res, Div Med Oncol, Dept Internal Med,Coll Med, Seoul, South Korea
[3] Yonsei Univ, Coll Med, Dept Surg, Seoul, South Korea
[4] Yonsei Univ, Coll Med, Dept Internal Med, Div Gastroenterol, Seoul, South Korea
[5] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Radiat Oncol, Seoul, South Korea
[6] Yonsei Univ, Coll Med, Dept Biomed Syst Informat, Div Biostat, Seoul, South Korea
[7] Yonsei Univ, Coll Med, Dept Radiol, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4076
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Phase II trial of paclitaxel and cisplatin as neoadjuvant chemotherapy for locally advanced gastric cancer
    Tsuburaya, Akira
    Nagata, Naoki
    Cho, Haruhiko
    Hirabayashi, Naoki
    Kobayashi, Michiya
    Kojima, Hiroshi
    Munakata, Yasuhiro
    Fukushima, Ryoji
    Kameda, Yoichi
    Shimoda, Tadakazu
    Oba, Koji
    Sakamoto, Junichi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (05) : 1309 - 1314
  • [22] Phase II trial of paclitaxel and cisplatin as neoadjuvant chemotherapy for locally advanced gastric cancer
    Akira Tsuburaya
    Naoki Nagata
    Haruhiko Cho
    Naoki Hirabayashi
    Michiya Kobayashi
    Hiroshi Kojima
    Yasuhiro Munakata
    Ryoji Fukushima
    Yoichi Kameda
    Tadakazu Shimoda
    Koji Oba
    Junichi Sakamoto
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 1309 - 1314
  • [23] Phase II trial of concurrent chemoradiotherapy consisting of two courses with S-1 and cisplatin for locally advanced esophageal cancer.
    Iwase, H.
    Shimada, M.
    Tsuzuki, T.
    Ryuge, N.
    Goto, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [24] A randomized phase II trial of docetaxel plus S-1 versus docetaxel plus cisplatin in advanced gastric cancer as a first-line treatment
    Jeung, H.
    Im, C.
    Rha, S.
    Ahn, J.
    Shin, S.
    Noh, S.
    Roh, J.
    Chung, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [25] Phase II trial of adjuvant gemcitabine plus cisplatin-based chemotherapy in patients with locally advanced bladder cancer
    Jin, James O.
    Lehmann, Jan
    Taxy, Jerome
    Huo, Dezheng
    Stokle, Michael
    Vogelzang, Nicholas J.
    Steinberg, Gary
    Stadler, Walter M.
    CLINICAL GENITOURINARY CANCER, 2006, 5 (02) : 150 - 154
  • [26] Phase 2 study of neoadjuvant durvalumab plus docetaxel, oxaliplatin, and S-1 with surgery and adjuvant durvalumab plus S-1 for resectable locally advanced gastric cancer
    Kang, Yoon-Koo
    Kim, Hyung-Don
    Cho, Hyungwoo
    Park, Young Soo
    Lee, Jong Seok
    Ryu, Min-Hee
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2025, 13 (03)
  • [27] Randomized phase III study of S-1 alone versus S-1+cisplatin in the treatment for advanced gastric cancer (The SPIRITS trial) SPIRITS: S-1 plus cisplatin vs S-1 in RCT in the treatment for stomach cancer
    Narahara, H.
    Koizumi, W.
    Hara, T.
    Takagane, A.
    Akiya, T.
    Takagi, M.
    Miyashita, K.
    Nishizaki, T.
    Kobayashi, O.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [28] A multicenter phase II study of preoperative chemoradiotherapy with S-1 plus oxaliplatin for locally advanced rectal cancer (SHOGUN trial)
    Matsusaka, Satoshi
    Ishihara, Soichiro
    Kondo, Keisaku
    Horie, Hisanaga
    Uehara, Keisuke
    Oguchi, Masahiko
    Murofushi, Keiko
    Ueno, Masashi
    Mizunuma, Nobuyuki
    Shimbo, Taiju
    Kato, Daiki
    Okuda, Junji
    Hashiguchi, Yojiro
    Nakazawa, Masanori
    Sunami, Eiji
    Kawai, Kazushige
    Yamashita, Hideomi
    Okada, Tohru
    Ishikawa, Yuichi
    Nakajima, Toshifusa
    Watanabe, Toshiaki
    RADIOTHERAPY AND ONCOLOGY, 2015, 116 (02) : 209 - 213
  • [29] Phase I trial of neoadjuvant concurrent chemoradiotherapy with S-1 and weekly irinotecan in locally advanced rectal cancer
    Choi, Hye Jin
    Kim, Nam-Kyu
    Keum, Ki Chang
    Cheon, Seong Ha
    Shin, Sang Jun
    Baik, Seung Hyuk
    Choen, Jae Hee
    Rha, Sun Young
    Roh, Jae Kyung
    Jeung, Hei-Cheul
    Chung, Hyun Cheol
    Ahn, Joong Bae
    RADIOTHERAPY AND ONCOLOGY, 2008, 87 (03) : 361 - 366
  • [30] Subgroup analyses of a randomized two-by-two factorial phase II trial comparing neoadjuvant chemotherapy with 2 and 4 courses of cisplatin/S-1 (CS) and docetaxel/cisplatin/S-1 (DCS) as neoadjuvant chemotherapy for locally advanced gastric cancer
    Hayashi, T.
    Yoshikawa, T.
    Sakamaki, K.
    Nishikawa, K.
    Fujitani, K.
    Tanabe, K.
    Ito, Y.
    Matsui, T.
    Miki, A.
    Fukunaga, T.
    Nemoto, H.
    Kimura, Y.
    Hirabayashi, N.
    ANNALS OF ONCOLOGY, 2019, 30
12345